Items per page

Search results

Items: 1 to 20 of 55

Search results: x Variables, w Analyses, x Documents, and z Datasets in x Studies
Clinical VariableDatasetVariable DescriptionVariable ID
The Non-Hodgkin Lymphoma (NHL) subject phenotype data table includes WHO diagnosis, progression and IPI score, gender, sequence of events (n=7 variables), perfomance and vital status (n=4 variables), cancer staging (n=3 variables), LDH ratio, treatment and response (n=3 variables), and hematopoietic stem cell transplant status (n=2 variables).
Number of days to primary treatment startphv00173812.v2.p2
The Non-Hodgkin Lymphoma (NHL) subject phenotype data table includes WHO diagnosis, progression and IPI score, gender, sequence of events (n=7 variables), perfomance and vital status (n=4 variables), cancer staging (n=3 variables), LDH ratio, treatment and response (n=3 variables), and hematopoietic stem cell transplant status (n=2 variables).
Number of days to progressive disease, if occurredphv00173815.v2.p2
The Non-Hodgkin Lymphoma (NHL) subject phenotype data table includes WHO diagnosis, progression and IPI score, gender, sequence of events (n=7 variables), perfomance and vital status (n=4 variables), cancer staging (n=3 variables), LDH ratio, treatment and response (n=3 variables), and hematopoietic stem cell transplant status (n=2 variables).
Largest tumor mass diameterphv00173809.v2.p2
The Non-Hodgkin Lymphoma (NHL) subject phenotype data table includes WHO diagnosis, progression and IPI score, gender, sequence of events (n=7 variables), perfomance and vital status (n=4 variables), cancer staging (n=3 variables), LDH ratio, treatment and response (n=3 variables), and hematopoietic stem cell transplant status (n=2 variables).
Performance status (ECOG)phv00173806.v2.p2
The Non-Hodgkin Lymphoma (NHL) sample attributes data table includes analyte type, library type, treatment status at sample acquisition, tissue site, tissue status, percent tumor, and disease project.
Treatment status at sample acquisitionphv00173828.v2.p2
The Non-Hodgkin Lymphoma (NHL) subject phenotype data table includes WHO diagnosis, progression and IPI score, gender, sequence of events (n=7 variables), perfomance and vital status (n=4 variables), cancer staging (n=3 variables), LDH ratio, treatment and response (n=3 variables), and hematopoietic stem cell transplant status (n=2 variables).
Number of days to HSCTphv00173819.v2.p2
The Non-Hodgkin Lymphoma (NHL) subject phenotype data table includes WHO diagnosis, progression and IPI score, gender, sequence of events (n=7 variables), perfomance and vital status (n=4 variables), cancer staging (n=3 variables), LDH ratio, treatment and response (n=3 variables), and hematopoietic stem cell transplant status (n=2 variables).
Status at last follow-upphv00173822.v2.p2
The Non-Hodgkin Lymphoma (NHL) sample attributes data table includes analyte type, library type, treatment status at sample acquisition, tissue site, tissue status, percent tumor, and disease project.
Sample Idphv00173825.v2.p2
The Non-Hodgkin Lymphoma (NHL) subject phenotype data table includes WHO diagnosis, progression and IPI score, gender, sequence of events (n=7 variables), perfomance and vital status (n=4 variables), cancer staging (n=3 variables), LDH ratio, treatment and response (n=3 variables), and hematopoietic stem cell transplant status (n=2 variables).
WHO diagnosisphv00173801.v2.p2
The Non-Hodgkin Lymphoma (NHL) subject phenotype data table includes WHO diagnosis, progression and IPI score, gender, sequence of events (n=7 variables), perfomance and vital status (n=4 variables), cancer staging (n=3 variables), LDH ratio, treatment and response (n=3 variables), and hematopoietic stem cell transplant status (n=2 variables).
Number of days to date transformed lymphoma diagnosedphv00173820.v2.p2
The Non-Hodgkin Lymphoma (NHL) subject phenotype data table includes WHO diagnosis, progression and IPI score, gender, sequence of events (n=7 variables), perfomance and vital status (n=4 variables), cancer staging (n=3 variables), LDH ratio, treatment and response (n=3 variables), and hematopoietic stem cell transplant status (n=2 variables).
Number of days to response assessmentphv00173814.v2.p2
The Non-Hodgkin Lymphoma (NHL) subject phenotype data table includes WHO diagnosis, progression and IPI score, gender, sequence of events (n=7 variables), perfomance and vital status (n=4 variables), cancer staging (n=3 variables), LDH ratio, treatment and response (n=3 variables), and hematopoietic stem cell transplant status (n=2 variables).
Secondary treatmentphv00173817.v2.p2
The Non-Hodgkin Lymphoma (NHL) subject phenotype data table includes WHO diagnosis, progression and IPI score, gender, sequence of events (n=7 variables), perfomance and vital status (n=4 variables), cancer staging (n=3 variables), LDH ratio, treatment and response (n=3 variables), and hematopoietic stem cell transplant status (n=2 variables).
Stage (Ann Arbor)phv00173804.v2.p2
The Non-Hodgkin Lymphoma (NHL) sample attributes data table includes analyte type, library type, treatment status at sample acquisition, tissue site, tissue status, percent tumor, and disease project.
Library Typephv00173827.v2.p2
The Non-Hodgkin Lymphoma (NHL) sample attributes data table includes analyte type, library type, treatment status at sample acquisition, tissue site, tissue status, percent tumor, and disease project.
Disease projectphv00259022.v1.p2
The Non-Hodgkin Lymphoma (NHL) subject phenotype data table includes WHO diagnosis, progression and IPI score, gender, sequence of events (n=7 variables), perfomance and vital status (n=4 variables), cancer staging (n=3 variables), LDH ratio, treatment and response (n=3 variables), and hematopoietic stem cell transplant status (n=2 variables).
Lactate dehydrogenase level (LDH) as ratio of measured value/upper limit of normalphv00173807.v2.p2
The Non-Hodgkin Lymphoma (NHL) sample attributes data table includes analyte type, library type, treatment status at sample acquisition, tissue site, tissue status, percent tumor, and disease project.
Tissue statusphv00173830.v2.p2
The Non-Hodgkin Lymphoma (NHL) subject phenotype data table includes WHO diagnosis, progression and IPI score, gender, sequence of events (n=7 variables), perfomance and vital status (n=4 variables), cancer staging (n=3 variables), LDH ratio, treatment and response (n=3 variables), and hematopoietic stem cell transplant status (n=2 variables).
Hematopoietic stem cell transplant (HSCT)phv00173818.v2.p2
The Non-Hodgkin Lymphoma (NHL) subject phenotype data table includes WHO diagnosis, progression and IPI score, gender, sequence of events (n=7 variables), perfomance and vital status (n=4 variables), cancer staging (n=3 variables), LDH ratio, treatment and response (n=3 variables), and hematopoietic stem cell transplant status (n=2 variables).
Number of days to last follow-upphv00173821.v2.p2
The Non-Hodgkin Lymphoma (NHL) subject phenotype data table includes WHO diagnosis, progression and IPI score, gender, sequence of events (n=7 variables), perfomance and vital status (n=4 variables), cancer staging (n=3 variables), LDH ratio, treatment and response (n=3 variables), and hematopoietic stem cell transplant status (n=2 variables).
Primary treatmentphv00173811.v2.p2
Items per page

Supplemental Content

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk